EPO Patents = 1

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Han-Chung Wu (3 out of 36 patents)

Tong-Young Lee (3 out of 5 patents)

Tanny Chen Tsao (3 out of 3 patents)

4. Willie Lin (3 out of 3 patents)

5. Nien-Yi Chen (1 out of 5 patents)

6. Che-Haorz Wu (1 out of 2 patents)

7. Winston Town (1 out of 2 patents)

8. Hung-Chi Chen (1 out of 5 patents)

4 patents: Sort by Forward Citations

1. 10370443 - Method of treating autoimmune disease by administering antibodies to interleukin-6 (2019-08-06),

2. 9758580 - Uses of antibodies to interleukin-6 in cancer treatment (2017-09-12),

3. 9540673 - Methods for producing recombinant glycoproteins with modified glycosylation (2017-01-10),

4. 9234035 - Antibodies to interleukin-6 (2016-01-12),

Company Overview

Fountain Biopharma Inc. is a leading biotechnology company focused on developing innovative therapies for a range of diseases. Our cutting-edge research and development efforts are dedicated to improving patient outcomes and advancing the field of healthcare. With a strong team of scientists and industry experts, we are committed to creating novel treatments that address unmet medical needs and make a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#924 in Taipei

#2,736 in Taiwan

Taipei, Taiwan

Fountain Biopharma Inc.

Forward Citations = 2

8 inventors:

Han-Chung Wu (3 out of 36 patents)

Tong-Young Lee (3 out of 5 patents)

Tanny Chen Tsao (3 out of 3 patents)

4. Willie Lin (3 out of 3 patents)

5. Nien-Yi Chen (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fountain Biopharma Inc.. Retrieved from https://idiyas.com/company/fountain-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]